| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), SLDB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.4K | $1.37M | - | |
| Dir | 141.6K | - | - | |
| COO | 105.1K | $611.9K | - | |
| CFO | 99.4K | $579.0K | - | |
| Other | 89.5K | $521.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Hanrahan Jessie | Chief Regulatory Officer | Sale+OE | 4,134 | $5.82 | $24,073.52 | -5.3% | +2.7% | - | |
| Feb 18, 2026 | Ganot Ilan58 | Director | Sale+OE | 2,658 | $5.82 | $15,478.33 | -8.8% | +2.7% | - | |
| Feb 18, 2026 | Brooks Gabriel | Chief Medical Officer | Sale+OE | 0 | $0.00 | - | - | +2.7% | - | |
| Feb 18, 2026 | Cumbo Alexander | President And CEO | Sale+OE | 16,644 | $5.82 | $96,923.01 | -6.6% | +2.7% | - | |
| Feb 18, 2026 | Howton David T | Chief Operating Officer | Sale+OE | 7,469 | $5.82 | $43,494.23 | -6.6% | +2.7% | - | |
| Feb 18, 2026 | Tan Kevin | CFO &Treasurer | Sale+OE | 5,404 | $5.82 | $31,469.11 | -5.2% | +2.7% | - | |
| Feb 18, 2026 | Herzich Paul | Chief Technology Officer | Sale+OE | 3,616 | $5.82 | $21,057.05 | -4.7% | +2.7% | - | |
| Jan 28, 2026 | Ganot Ilan58 | Director | Sale+OE | 191 | $6.59 | $1,258.69 | -1.1% | +13.7% | - | |
| Jan 13, 2026 | Tan Kevin | CFO &Treasurer | Sale+OE | 5,704 | $5.27 | $30,060.08 | -11.0% | +55.4% | - | |
| Jan 5, 2026 | Ganot Ilan58 | Director | Sale+OE | 1,053 | $5.43 | $5,717.79 | -5.7% | +45.2% | - |